Investing Profile

Roger Zhang

InvestorVC
Senior Associate at Samsara BioCapital
samsaracap.com/roger-zhang/Stanford, California
Photo of Roger Zhang, Associate at Samsara BioCapital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stanford University Network
705 CONNECTIONS
The University of British Columbia Network
26 CONNECTIONS
Stanford University School of Medicine Network
25 CONNECTIONS
Stanford Center for Clinical Research (SCCR) Network
13 CONNECTIONS
Roche Network
12 CONNECTIONS
$10.0M - $100.0M
$25.0M
$310.1M
Senior Associate Samsara BioCapital2023 - Present
VP Aulis CapitalPresent
VP Samsara BioCapitalPresent
Board Observer Candid TherapeuticsPresent
Board Observer Pathalys PharmaPresent
Board Member Link Cell TherapiesPresent
Board Observer Kalaris TherapeuticsPresent
PhD Student Stanford Center for Clinical Research (SCCR)Present
Virology Intern F. Hoffmann-La Roche LtdPresent
Board Member SpyGlass Pharma, Inc.2023 - 2025
Board Member Respira Therapeutics, Inc.2021 - 2025
Associate Samsara BioCapital2021 - 2023
Board Observer Mineralys Therapeutics, Inc.2021 - 2023
Board Observer CARGO Therapeutics2021 - 2023
Senior Analyst Samsara BioCapital2020 - 2021
PhD Student Stanford University School of Medicine2014 - 2020
Virology Intern Roche2012 - 2013
Stanford University Doctor of Philosophy (Ph.D.) Molecular and Cellular Physiology
The University of British Columbia Bachelor of Science (B.Sc.) Pharmacology